Start
September 28, 2026 - 1:00 pm
End
September 28, 2026 - 2:30 pm
Monday, 28 September | 13:00–14:30 CEST | English with live translation into Spanish
Join a compelling 90-minute global webinar exploring the growing “pandemic” of insulin resistance and its far-reaching impact on metabolic and reproductive health. Led by internationally renowned experts, this session will tackle obesity, PMOS (formerly PCOS), gestational diabetes, prediabetes, and early type 2 diabetes through a practical, multidisciplinary lens.
Designed for endocrinologists, primary care physicians, nurses, and allied specialists, the programme will combine cutting-edge evidence with real-world strategies—from diagnosis and risk stratification to lifestyle, pharmacological, and digital interventions. With expert insights spanning Australia, India, and Turkey, and a live Q&A, participants will gain actionable guidance to optimise patient outcomes, strengthen collaborative care models, and drive prevention efforts.
We are excited to share that we will be joined by a captivating expert-led panel:
- ISE President, Prof. Helena Teede (Australia)
- Assoc. Prof. Anju Joham (Australia)
- Prof. Nikhil Tandon (India)
This webinar, moderated by Prof. Bulent Yildiz (Turkey), brings together these internationally renowned experts to examine some of the most pressing challenges we are facing in endocrinology today.
Why should you attend?
- Improve recognition and management of gestational diabetes, prediabetes and early type 2 diabetes
- Understand the links between obesity, PMOS and metabolic health
- Explore evidence-based lifestyle and pharmacological treatment strategies
- Learn how multidisciplinary care can improve patient outcomes
- Gain practical insights from leading international experts and apply them in clinical practice.
Register today and join the interdisciplinary conversation on the interconnected challenges of insulin resistance and how to increase early detection rates of prediabetes and early T2DM, and reduce long-term complications of metabolic disorders.
This activity is supported by an educational grant from Merck KGaA, Darmstadt, Germany. The webinar will be conducted in English with live interpretation to Spanish.